Home
overview

*** NEW INTERVIEWS RELEASED! ***

Visit the download centre for some exclusive pre-show interviews with some of our key speakers.

Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.

Whilst still in its infancy, 3D Cell Culture is rapidly growing with not only a widespread reach that can be seen across a number of different fields such as 3D bioprinting and microfluidics, but also with incredible potential for industrial application. The 2nd annual conference will explore these overlapping areas and will also update delegates on pioneering developments in surrounding topics such as disease models, organoids, organ-on-a-chip technologies and iPSC advances.
 

Attendee testimonials from 2017:

“Very good presentations and a few outstanding ones...I made some useful contacts” Asterand Bioscience
“The conference was wonderfully organised” Novartis
“Good start, love to see the event occur again” Thermo Fisher Scientific
 

  • Uncover the biology of human neurodevelopment diseases in 3D by merging cutting edge technologies in CRISPR editing and single cell sequencing
  • Take a 3D biology approach to overcome challenges for cell based screening with exclusive insight into electrospun micro-scaffold based biology
  • Develop strategies for optimising placement of cells in printing by identifying key developments in the overlap of 3D bioprinting and 3D cell culturing
  • Identify new approaches to predictive substance testing through innovative case study insight into multi-organ-chip technology
  • Benefit from an agenda tailored towards driving clinical development through ground breaking case studies on the Zika virus and tuberous sclerosis
  • Adapt current microfluidic culture methods into large scale manufacturing


 

Join us this year to network with our growing community. Previous attendees include:

Aber; Aber Instruments Ltd; Adaptimmune Ltd; Aptuit (Verona) S.r.l; Asterand Bioscience; AstraZeneca; Barts Cancer Institute; Bial; Biogelx Ltd; BioTek Instruments Ltd.; Boehringer-Ingelheim; Cellesce Limited; Cellon S.A; Cellular Dynamics International; Corning; Department of Craniofacial Development and Stem Cell Biology; Durham University; EPISKIN SA; Epithelix; F. Hoffmann-La Roche AG; F. Hoffmann-La Roche Ltd.; GE Healthcare; GlaxoSmithKline; GSK; Hubrecht Institute; Immunocore Ltd; Imperial College; Imperial College London; Jellagen Pty Ltd; Kings College London; King's College London; Kings College School Of Medicine And Dentistry; Lonza Incorporated; Medical Research Council; MHRA; Microduits GmbH; Neem Biotech Ltd; Nexcelom; NIFES; Novartis Institutes For Biomedical Research; Novartis Pharmaceuticals; Pfizer; Plasticell Ltd; ProDigest; Progen Biotechnik GmbH; Reinnervate; Roche Diagnostics ; Samedan Ltd; Sanofi; Sigma Aldrich; Stemtek Therapeutics; tebu-bio; Technologie Servler; The Scripps Research Institute; Thermo Fisher Scientific; TissUse GmbH; Unilever Research Colworth; university surrey; Ventana Medical System, Inc + more!

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Stefan Przyborski

Stefan Przyborski, Professor of Cell Technology, University of Durham
View Bio

9:10 3D Cell Culture – A Rapidly Developing Series of Technologies Enabling the Evolution of Complex Models of Human Tissues and In Vitro Assays

Stefan Przyborski

Stefan Przyborski, Professor of Cell Technology, University of Durham
View Bio

  • 3D vs 2D cell culture – the similarities and differences between both methods;
  • Demand for 3D cell culture;
  • No one solution - alternative techniques: organoids, spheroids, hydrogels and scaffolds;
  • Examples of current applications –simple 3D cultures to engineering complex tissues;
  • Case example – building layered tissue structures to model the anatomy and physiology of native counterparts;
  • New developments in 3D cell culture and related technologies
     
  • 9:50 Electrospun micro-scaffold based biology – a 3-D biology approach to overcome many challenges for well-based screening

    Gary Allenby

    Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Bioscience
    View Bio

    Electrospun scaffold material is used in regenerative medicine to grow, differentiate and deliver stem cells into patients – we have developed practical approaches to use this material for 3-D screening purposes
    Our primary cells, differentiated stem cells and recombinant cells grow on and into micro-scaffold islands, effectively 3-D micro-tissues on a matrix in micro-wells and in media
    By incorporating iron particles into the scaffold material, we can physically manipulate the micro-scaffolds with magnetism, moving these around wells of plates and tubes in culture
    We will show data from a number of assay readouts to exemplify the simplicity of the approach for cell-based phenotypic screening together with advantages of this approach for assay biology

    10:30 Morning Coffee

    11:00 Next generation jellyfish collagen – Applications for 3D cell culture

    Andrew Spragg

    Andrew Spragg, CEO, Jellagen Pty Ltd

  • Jellyfish collagen biomaterials and why considered to be next generation
  • 2D applications
  • Overview of possible 3D applications
  • Future potential for research and medical applications
  •  

    11:40 The potential of advanced cell culture models for the understanding of disease and compound testing

    Vitor Santo

    Vitor Santo, Senior Scientist, IBET (Instituto de Biologia Experimental e Tecnologica)
    View Bio

  • There is an increasing demand for the application of more predictable cell models in drug discovery. These models should be able to reflect human tissue properties and functionality more faithfully, enabling to recapitulate in vitro certain features of tissue microenvironment.
  • Pathophysiological-relevant cell models require the existence of cell-cell, cell-extracellular matrix and soluble factors to caption tissue complexity at a certain extent.
  • Increase in complexity of model design must be accompanied by the application of more advanced characterization tools and read-outs.
     
  • 12:20 Networking Lunch

    13:30 Direct tissue engineering approaches for regenerative biology and medicine

    Suwan Jaysinghe

    Suwan Jaysinghe, Professor of Bioengineering, University College London

  • Technological application in cell culture and expansion
  • Biological model development
  • Tissues development in a dish, for drug development and screening etc.
  • Reconstruction of tissues for repair, replacement and rejuvenation
  • 14:10 Can 3D cell culture improve the prediction of hepatotoxicity in early phase screening?

    Christopher Schofield

    Christopher Schofield, Investigator, GSK
    View Bio

  • Development of a 3D primary human hepatocyte in vitro model
  • Comparison to current 2D and other complex in vitro models
  • Industrialisation for compound screening and further characterisation
  • The results of a validation compound set
  • 14:50 Afternoon Tea

    15:20 Merging CRISPR-editing and single cell sequencing technologies to uncover the biology of human neurodevelopmental diseases in 3D: case studies with Zika virus and tuberous sclerosis

    Max Salick

    Max Salick, Postdoctoral Researcher, Novartis Institutes For Biomedical Research
    View Bio

  • CRISPR-engineered human stem cell lines mimic disease phenotypes during 3D cerebral organoid differentiation
  • Selective removal of target genes in cerebral organoids reveals the biology of Zika virus infection
  • Whole-genome CRISPR screens enable the discovery of new proteins linked to tropism of emerging infectious diseases
  • Single cell sequencing allows researchers to investigate cell-type specific effects of mutations, treatments, or other perturbations in complex 3D tissues

     

  • 16:00 The UKRMP – a national strategic initiative

    David Pan

    David Pan, Programme Manager (Regenerative Medicine), UK Regenerative Medicine Platform
    View Bio

  • What are the key challenges for regenerative medicine?
  • What is the ambition and of the UK’s strategic approach?
  • Overview of developments, current standings and forward plans
  • 16:40 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Gary Allenby

    Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Bioscience

    9:10 The overlap of 3D bioprinting and 3D cell culturing in Cancer Research

    Nicholas Leslie

    Nicholas Leslie, Professor, Heriot-Watt University
    View Bio

  • Overview of 3D bioprinting
  • The reliance of 3D bioprinting on spheroid models and cell organisation
  • How to achieve correct architecture, based on different disease models
  • How improving placement of cells in printing can translate into improved model
  • The synonymy of 3D bioprinting and 3D cell culture
     
  • 9:50 Multi-Organ-Chip technology: A completely new approach to predictive substance testing

    Reyk Horland

    Reyk Horland, Head of Business Development, TissUse GmbH
    View Bio

  • Definition and overview of Organ-on-a-Chip (OOC) systems
  • Scientific concept, design principles and fabrication of OOC
  • Case studies on industrial applications off OOC
  • Qualification and validation of OOC
  • Roadmap towards individual “Patients-on-a-Chip”
  • 10:30 Morning Coffee

    11:00 Complex co-cultured spheroids to validate tumour models in microfluidic devices

    Tudor  Petreus

    Tudor Petreus, PostDoctoral Researcher, AstraZeneca
    View Bio

  • Overview on the tumour-on-chip models
  • Development of in vitro prevascularized minitumours – current progress and optimization
  • Prevascularized tumour models in cancer research
  • 11:40 Keep up to speed with fast whole well imaging using the Celigo image cytometer for all your 2D and 3D assay needs

    Scott Cribbes

    Scott Cribbes, Director of New Technologies and Emerging Markets, Nexcelom

    12:20 Networking Lunch

    13:30 3D cellular models for drug safety assessment: an industry perspective

    Stefan Kustermann

    Stefan Kustermann, Lab Head, Roche Pharma Schweiz AG

     

  • There is a strong need for complex in vitro models for drug safety assessment recapitulating human physiology to a high degree
  • This is supported by an ever increasing complexity of modalities and targets with a strong need for human in vitro models
  • Novel human 3D cellular models will be presented and their impact for drug safety assessment will be discussed
  • 14:10 How laws of nature should guide the development of 3D cell culture for regenerative medicine

    Patrick Kugelmeier

    Patrick Kugelmeier, Director of Science, Kugelmeiers
    View Bio

  • We are learning the language of life. Stem cell communication principles.
  • First principle reasoning – how stem cell communication principles influence medical device development
  • Challenges on the way to the largest evolution of medicine in history
  • 14:50 Afternoon Tea

    15:20 Towards bioprinting industrialisation

    Guillemot Fabien

    Guillemot Fabien, CEO, Poietis

  • Designing and manufacturing bio-printed products for regenerative medicine

  • Preclinical research and evaluation of the efficacy of cosmetic products and ingredients

  • The ability to design and manufacture tissues with a single cell resolution

  • Ensuring precise control of the manufacturing process and guarantee the reproducibility and reliability of bio-printed products

  • 16:00 3D-culture strategies for the generation of stem cell-derived beta cells

    Diana Ribeiro

    Diana Ribeiro, Industrial PhD Student, AstraZeneca

  • Comparison of 2D vs 3D culture on stem cell derived pancreatic models.

  • 3D-culture effect on islets phenotype and function in vitro.

  • Applications of decellularized pancreas tissue for stem cell differentiation

     

  • 16:40 Development of processing platforms for allogeneic cell therapy manufacturing

    Ricardo Baptista

    Ricardo Baptista, Lead Scientist Process Development, Cell and Gene Therapy Catapult
    View Bio

  • Expansion of pluripotent stem cells in 2D and 3D culture systems
  • Starting materials compliant with industry standards and regulatory requirements
  • Medium performance
  • Process intensification
  • 17:20 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Christopher Schofield

    Christopher Schofield

    Investigator, GSK
    Max Salick

    Max Salick

    Postdoctoral Researcher, Novartis Institutes For Biomedical Research
    Patrick Kugelmeier

    Patrick Kugelmeier

    Director of Science, Kugelmeiers
    Tudor  Petreus

    Tudor Petreus

    PostDoctoral Researcher, AstraZeneca

    Andrew Spragg

    CEO, Jellagen Pty Ltd
    Andrew Spragg

    Christopher Schofield

    Investigator, GSK
    Christopher Schofield

    Chris Schofield is an investigator in the Protein and Cellular Sciences department at GlaxoSmithKline R&D, Stevenage. He obtained his undergraduate degree in Applied Biology from the University of Coventry. Joining GSK in 1995 he has gained over 20 years industrial experience in protein expression supporting small molecule drug discovery. He specialised in development of laboratory and pilot plant scale mammalian and insect cell culture systems including large scale baculovirus, bacMam and other transient systems. His cell culture expertise contributed to the development and implementation of frozen cell technology and the use of frozen isolated mitochondria from cell lines for high throughput screening. He is currently investigating the use of precision cut tissue slices and 3D cell culture models in early drug discovery.

    David Pan

    Programme Manager (Regenerative Medicine), UK Regenerative Medicine Platform
    David Pan

    David obtained his PhD from the University of Sydney, Dept of Medicine (Endocrinology) and spent several years in both academic research and drug discovery in the biotech industry at OSI Pharmaceuticals/Prosidion Ltd. David is currently the Programme Manager for the UK Regenerative Medicine Platform (UKRMP). The UKRMP is a £25M initiative, funded by the MRC, EPSRC BBSRC that aims to address technical and scientific challenges associated with translating promising scientific discoveries in this area towards clinical impact. As Programme Manager, he provides the key point of contact between the regenerative medicine community and funding agencies.

    Diana Ribeiro

    Industrial PhD Student, AstraZeneca
    Diana Ribeiro

    Gary Allenby

    Business Development Director and Chief Scientific Officer, Aurelia Bioscience
    Gary Allenby

    After completing a Ph.D. in reproductive toxicology I post-doc’ed at Hoffmann La Roche U.S.A, studying the pharmacology of retinoid biology. I returned to the U.K. into Lead Generation at Glaxo Wellcome, developing cell-based assays and working with vendors to validate new technologies for screening. In 2000 I joined Hit Identification at AstraZeneca, developing assays for respiratory and inflammatory disease and continuing to work with vendors. In 2011 I became a founding entrepreneur of Aurelia Bioscience, a pre-clinical contract research organisation specialising in the development of cell-based assays for compound and biologics screening. Our unique selling point is the development of more physiological phenotypic assays.
     

    Guillemot Fabien

    CEO, Poietis
    Guillemot Fabien

    Max Salick

    Postdoctoral Researcher, Novartis Institutes For Biomedical Research
    Max Salick

    Max Salick is a postdoctoral scholar in the Neuroscience Department of the Novartis Institutes for Biomedical Research in Cambridge, Massachusetts. Max’s research has merged CRISPR gene-editing, 3D human cerebral organoid models, and high-throughput single cell trascriptomics to uncover the mechanisms of both genetic and infectious neurodevelopmental diseases. Through this combination of molecular, computational, and stem cell biology, Max’s work has helped to unlock the viral tropism of Zika virus, as well as the effects of tuberous sclerosis on brain formation and function.

    Nicholas Leslie

    Professor, Heriot-Watt University
    Nicholas Leslie

    Nick is a cancer cell biologist and a Professor at Heriot Watt University in Edinburgh. He studied Genetics at Cambridge and Glasgow Universities before research work at the Beatson Institute for Cancer Research and Dundee University, addressing cellular control mechanisms which are disturbed in many cancers. In particular, Nick has extensively studied the tumour suppressor PTEN, the function of which is disrupted in around a third of all cancers. At HWU, much of his lab’s research is in collaboration with engineers, applying biofabrication methods and other new technologies to cancer research. His 80+ publications currently accumulate >400 citations per year.

    Patrick Kugelmeier

    Director of Science, Kugelmeiers
    Patrick Kugelmeier

    Patrick Kugelmeier studied medicine and did his medical thesis in islet transplantation for the treatment of Diabetes. The joy of research led to an MD-PhD program for the early differentiation of stem cells. Cell culture technologies at that time didn't allow for good data reproducibility, because stem cells were cultured in 2D. Fueled by the clinical need of small, size-controlled cell clusters to improve islet transplantation and the insights from the sensitivity of stem cells, he began to develop what was later to become the Sphericalplate 5D.
    After the MD-PhD program, he did his clinical training in visceral and transplant surgery followed by trauma surgery. Besides the clinical work, the Sphericalplate 5D was further developed. Finally, it became clear that this technology opens a new dimension in cell transplantation and regenerative medicine and Dr. Kugelmeier decided to quit surgery to fully live this vision within a startup-company, the Kugelmeiers AG.
     

    Reyk Horland

    Head of Business Development, TissUse GmbH
    Reyk Horland

    Since 2010 Reyk is actively involved in the development of TissUse’s Multi-Organ-Chip platform for culture analysis of drug candidates, cosmetics, chemicals and consumer products. He currently holds the position of Head of Business Development at TissUse. Prior to TissUse Reyk studied Biotechnology at the Technische Universität Berlin and specialized in Medical Biotechnology. During his academic career, he was involved in various tissue-engineering programs, all with a focus on bringing the respective products to market.

    Ricardo Baptista

    Lead Scientist Process Development, Cell and Gene Therapy Catapult
    Ricardo Baptista

    Ricardo Baptista hold the role of Lead Scientist of the Industrialisation Team at The Cell and Gene Therapy Catapult, London, UK. He is currently working on the development of scalable bioprocesses for the manufacture of allogeneic therapies derived from human pluripotent stem cells. He is also involved in projects aiming the automation and translation of bioprocesses for cell therapy manufacture. Previously to Cell Therapy Catapult, Ricardo held the role of Project Manager and Scientist in Product and Process Development Team at CCRM-Centre for Commercialization of Regenerative Medicine, in Canada. Ricardo is a Biological Engineer and obtained his PhD degree in Biotechnology and Biochemical Engineering.

    Scott Cribbes

    Director of New Technologies and Emerging Markets, Nexcelom
    Scott Cribbes

    Stefan Kustermann

    Lab Head, Roche Pharma Schweiz AG
    Stefan Kustermann

    Stefan Przyborski

    Professor of Cell Technology, University of Durham
    Stefan Przyborski

    Professor Przyborski holds an academic position as Professor in Cell Technology at Durham University. He has over 25 years experience in cell biology with specific interests in cell culture technology, neuroscience and stem cell research. In recent years he has developed a multi-disciplinary approach through collaborative projects with physical scientists to develop novel ways of solving biological problems. He has formed alliances with pharmaceutical and biotech companies, has published over 100 scientific papers and has filed several patents. He is also the founder and Chief Scientific Officer of Reinnervate (now part of ReproCELL Europe), a biotechnology company founded in 2002 as a spinout from Durham University UK. Professor Przyborski is developing new and innovative ways to manage the growth and function of cultured cells. These enabling technologies have multiple applications and will be particularly relevant to building models of human tissues to advance basic research and drug discovery.
     

    Suwan Jaysinghe

    Professor of Bioengineering, University College London
    Suwan Jaysinghe

    Tudor Petreus

    PostDoctoral Researcher, AstraZeneca
    Tudor  Petreus

    2004 - 2014 lecturer and assistant professor of Cell Biology in the University of Medicine and Pharmacy Iasi, Romania (English French and Romanian classes), Laboratory medicine specialist. Erasmus mobility in tissue engineering (France, 2002, 2010, 2011). 2014 - 2016 - postdoc in AstraZeneca UK, implementing Human Microtissue Body-on-a-Chip microfluidic devices to enhance translation of anti-tumour drug efficacy and safety prediction to the clinic. Since 2016, second postdoc in AstraZeneca UK, responsible for development of complex 3D tumour models in microfluidic devices and their use to evaluate the therapeutic index of drug combinations.
     

    Vitor Santo

    Senior Scientist, IBET (Instituto de Biologia Experimental e Tecnologica)
    Vitor Santo

    Vítor Espírito Santo is currently a Senior Scientist at the Preclinical Biology Department at Immunocore (UK), the world’s leading T cell receptor (TCR) company developing biological drugs to treat cancer, and infections and autoimmune diseases. He has also worked at iBET (Portugal), both as Post-Doc researcher and as a Senior Scientist, where he committed to the generation of novel 3D cancer cell models for drug screening and target validation, using co-culture strategies and patient-derived material in translational medicine approaches. He graduated in Biomedical Engineering (2007) at Univ. of Minho (Portugal), holds a PhD degree in Tissue Engineering, Regenerative Medicine and Stem cells (2012) from Univ. of Minho (Portugal) in collaboration with Kyoto Univ. (Japan). He accounts for more than 30 publications in international peer-reviewed journals.

    Sponsors and Exhibitors

    Official Media Partner

    Supporters

    Workshops

    3D bioprinting and other biofabrication methods
    Workshop

    3D bioprinting and other biofabrication methods

    Holiday Inn London - Kensington
    20th February to 21st February 2018
    London, United Kingdom

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    An Interview with Vitor Santo, Senior Scientist, Immunocore

    Download

    An interview with Stefan Przyborski

    Download

    An Interview with Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Bioscience

    Download

    Sponsors and Exhibitors


    Jellagen

    Sponsors and Exhibitors
    http://www.jellagen.co.uk/

    Jellagen Pty Ltd is a Med-Tech business manufacturing next generation collagen products sourced from Jellyfish for application in 2D and 3D cell culture and medical devices. Jellagen’s research grade materials are distributed into the global cell culture and stem cell research markets. Jellagen’s collagen products offers the potential of in vitro to in vivo applications as well as batch to batch consistency offering advantages to research and medical applications.


    Nexcelom

    Sponsors and Exhibitors
    http://www.nexcelom.co.uk

    Nexcelom’s Cellometer and Celigo S image cytometry products are designed for cell analysis in life science and biomedical research. The Cellometer instruments cover basic cell counting, viability and cell-based assays with 20uL of sample. The Celigo S is a high throughput fast micro-well 2D and 3D image cytometer. Nexcelom products are help researchers all over the world.

    Media Partners


    RegMedNet

    Official Media Partner
    https://www.regmednet.com

    RegMedNet is a networking site that unites all members of the diverse regenerative medicine community, enabling them to share the latest news, inspiration and insights, and connect and collaborate in order to help this exciting field move forward at an even faster rate.


    3DMedNet

    Official Media Partner
    https://www.3dmednet.com/

    3DMedNet is a network that unites all members of this diverse community, enabling connection and collaboration and providing expert resources that will help this exciting field move forward at an even faster rate.

    Media Partners


    Select Science

    Supporters
    http://www.selectscience.net/

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Labiotech.eu

    Supporters
    http://labiotech.eu

    Labiotech.eu is the leading digital media covering the European Biotech industry. It is used by over 55000 people monthly to keep a watch on the business and innovations of biotechnologies.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    SciDoc Publishers

    Supporters
    http://www.scidoc.org

    SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals - Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications - online.


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 116 titles and 200 plus open access journals and print/online book series (Bentham eBooks). Bentham Science answers the information needs of the pharmaceutical and biomedical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.113) and Current Medicinal Chemistry (Impact Factor 4.859): FREE online journals and information: www.benthamscience.com


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    PWTV

    Supporters
    www.pharmaworld.tv

    The dedicated Audio Visual file sharing platform for the Pharmaceutical, Life Sciences and The Animal Health Industry. Use the power of Audio and Visual to give a clearer information to your clients. www.pharmaworld.tv


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    Samedan

    Supporters
    http://www.samedanltd.com/magazine/13.

    International Clinical Trials (ICT) is a quarterly magazine edited by Dr Graham Hughes, and written by specialists at the forefront of clinical research. ICT’s coverage of operational developments ranges from adaptive designs in early phase trials through to post marketing research. ICT’s targeted readership consists of key decision makers across the pharmaceutical and biotech industries, along with contract partners and consultants. The magazine is distributed to pharmaceutical professionals in Europe and North America, and is accessed globally online. Read the latest issues, explore the ICT archive and subscribe at www.samedanltd.com/magazine/13.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.